J2KBIO Co., Ltd. (KOSDAQ:420570)
8,700.00
+450.00 (5.45%)
At close: Oct 16, 2026
| Market Cap | 50.87B +0.9% |
| Revenue (ttm) | 43.90B +51.0% |
| Net Income | 5.81B +401.8% |
| EPS | 994.22 +392.5% |
| Shares Out | 5.85M |
| PE Ratio | 8.75 |
| Forward PE | n/a |
| Dividend | 250.00 (2.87%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 10,164 |
| Open | 8,660.00 |
| Previous Close | 8,250.00 |
| Day's Range | 8,240.00 - 8,830.00 |
| 52-Week Range | 6,710.00 - 12,860.00 |
| Beta | 0.33 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 12, 2026 |